Clearside Biomedical (NASDAQ:CLSD) Rating Lowered to Sell at StockNews.com
Clearside Biomedical (NASDAQ:CLSD – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Tuesday. A number of other equities research analysts have also issued reports on CLSD. HC Wainwright reiterated a “buy” rating and set a $6.00 target price on shares […]
Clearside Biomedical (NASDAQ:CLSD – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Tuesday. A number of other equities research analysts have also issued reports on CLSD. HC Wainwright reiterated a “buy” rating and set a $6.00 target price on shares […]
